Closing Bell: Major gains for major averages, three CEOs talk earnings 7/19/22
Closing Bell
00:00
Sandos
Sandos had a good quarter, and it really was driven by a few factors. The recovery of health care systems around the world, driving demand for generic medicines. And we also got back to launching medicines and our ke geographies like europe and japan. We raised our overall top line outlook for sandos, and so we feel good about where the business is now. Looking ahead, we're on tract to read out our strategic review before the end of this year.
Play episode from 10:56
Transcript
